Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

6.2%

4 terminated/withdrawn out of 65 trials

Success Rate

93.2%

+6.6% vs industry average

Late-Stage Pipeline

48%

31 trials in Phase 3/4

Results Transparency

25%

14 of 55 completed trials have results

Key Signals

4 recruiting14 with results

Enrollment Performance

Analytics

Phase 3
29(46.0%)
Phase 2
28(44.4%)
Phase 1
4(6.3%)
Phase 4
2(3.2%)
63Total
Phase 3(29)
Phase 2(28)
Phase 1(4)
Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (65)

Showing 20 of 65 trials
NCT06722729Phase 2Completed

A Late Phase II Clinical Trial of KDT-3594 in Patients With Parkinson's Disease

Role: lead

NCT07040137Phase 3Active Not Recruiting

Confirmatory Study 3 of KPS-0373 in Patients With Spinocerebellar Degeneration

Role: lead

NCT07604064Phase 2Recruiting

A Clinical Trial of Olutasidenib in Patients With Acute Myeloid Leukemia

Role: lead

NCT07015268Phase 3Active Not Recruiting

A Clinical Study of KLH-2109 in Patients With Endometriosis

Role: lead

NCT03802617Phase 2Completed

A Clinical Study of MR13A9 in Hemodialysis Patients With Pruritus.

Role: lead

NCT05445167Phase 3Completed

A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia and Pain

Role: lead

NCT04711603Phase 3Completed

A Phase III Clinical Study of MR13A9 in Hemodialysis Patients With Pruritus.

Role: lead

NCT04132050Phase 3Completed

A Clinical Study in Patients With Chronic Idiopathic Thrombocytopenic Purpura in R788

Role: lead

NCT06611696Phase 4Recruiting

Avacopan vs Reduced-dose Glucocorticoids in ANCA-associated Vasculitis

Role: collaborator

NCT03992846Phase 3Completed

Efficacy and Safety of Linzagolix for the Treatment of Endometriosis-associated Pain.

Role: lead

NCT04335591Phase 3Completed

Extension to Study on Efficacy and Safety of Linzagolix for the Treatment of Endometriosis-associated Pain (EDELWEISS 6)

Role: lead

NCT04372121Phase 3Terminated

Extension to Study on Efficacy and Safety of Linzagolix for the Treatment of Endometriosis-associated Pain

Role: lead

NCT03986944Phase 3Terminated

A Phase 3 Study to Confirm the Efficacy and Safety of Linzagolix to Treat Endometriosis-associated Pain

Role: lead

NCT05831670Phase 2Completed

An Early Phase 2 Clinical Study of KSP-0243

Role: lead

NCT05440383Phase 3Completed

A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia

Role: lead

NCT06758271Recruiting

Special Drug Use-results Survey for Long-term Use(Avacopan)

Role: lead

NCT06757257Recruiting

Special Drug Use-results Survey for Long-term Use (Fostamatinib)

Role: lead

NCT03531892Phase 3Completed

A Study to Evaluate the Safety and Efficacy of AJM300 in Participants With Active Ulcerative Colitis

Role: collaborator

NCT04867551Phase 2Completed

A Clinical Study of KDT-3594 in Japanese Patients With Early Parkinson's Disease

Role: lead

NCT03845387Phase 2Completed

A Clinical Study of KDT-3594 in Patients With Early Parkinson's Disease.

Role: lead